The Claim
Isoprenaline stimulates lipolysis in isolated human subcutaneous adipose tissue in vitro, whereas glucagon and GLP-1 do not stimulate lipolysis under the same conditions.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In laboratory tests using human fat tissue, isoprenaline triggers the breakdown of fat, but glucagon and GLP-1 do not trigger fat breakdown under the same conditions.
See the scientific wording
Isoprenaline stimulates lipolysis in vitro in isolated human subcutaneous adipose tissue, while glucagon and GLP-1 do not, suggesting tissue-level differences in lipolytic responsiveness.
Isoprenaline binds to specific receptors on fat cells, turning on a chain reaction that breaks down stored fat into free fatty acids. Glucagon and GLP-1 do not activate these same receptors in fat tissue, so they do not trigger fat breakdown.
What the research says
1 studyIn lab tests on human fat tissue, isoprenaline made fat break down a lot, but glucagon and GLP-1 did nothing — so the fat cells respond differently to these hormones.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.